logo-horizontal-main.png
Oncocyte Signs Leading Transplant Centers in US and Germany
02 oct. 2024 18h41 HE | OncoCyte Corporation
GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volumeCompany clears first stage gate in clinical product development process and has...
logo-horizontal-main.png
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
02 oct. 2024 18h35 HE | OncoCyte Corporation
IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that it has entered into a...
logo-horizontal-main.png
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
12 août 2024 16h10 HE | OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Beta Costumer Revenue Path
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
08 août 2024 16h05 HE | OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
logo-horizontal-main.png
Oncocyte Announces August Investor Conferences Participation
05 août 2024 16h05 HE | OncoCyte Corporation
Oncocyte Announces August Investor Conferences Participation
logo-horizontal-main.png
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
01 août 2024 16h05 HE | OncoCyte Corporation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
logo-horizontal-main.png
Oncocyte Appoints Andrea James as Chief Financial Officer
17 juin 2024 16h05 HE | OncoCyte Corporation
Oncocyte Appoints Seasoned Finance Executive Andrea James as Chief Financial Officer
logo-horizontal-main.png
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
30 mai 2024 16h47 HE | OncoCyte Corporation
Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...
logo-horizontal-main.png
Oncocyte Reports First Quarter 2024 Financial Results
15 mai 2024 16h05 HE | OncoCyte Corporation
ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
logo-horizontal-main.png
Oncocyte to Announce First Quarter 2024 Financial Results
13 mai 2024 08h00 HE | OncoCyte Corporation
Oncocyte to Announce First Quarter 2024 Financial Results